Home › Myelofibrose › Florida › Miami
Myelofibrose klinische studies in Miami, FL
10 studies voor Myelofibrose zoeken deelnemers op locaties in en rond Miami (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
RekruterenFase 1/2
- University of Miami, Miami
- Baptist Health - Miami Cancer Institute, Miami
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
RekruterenFase 3
- Miami NS Ins Baptist Health S FL, Miami
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
RekruterenFase 3
- Bioresearch Partners, Miami
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RekruterenFase 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RekruterenFase 1/2
- Sylvester Cancer Center - U Miami, Miami
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RekruterenFase 1
- University of Miami, Miami
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
RekruterenFase 1
- University of Miami Health System, Miami
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RekruterenFase 2
- University of Miami, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Miami
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
RekruterenFase 3
- University of Miami, Miami
Myelofibrose studies in andere steden
- Houston, TX19 studies
- New York City, NY18 studies
- Boston, MA12 studies
- Durham, NC12 studies
- Columbus, OH11 studies
- Seattle, WA11 studies
- Salt Lake City, UT10 studies
- Nashville, TN9 studies
- Cleveland, OH9 studies
- Tampa, FL9 studies
- Atlanta, GA9 studies
- Baldwin Park, CA9 studies
Andere studies in Miami
- Borstkanker42 studies
- Kanker (alle vormen)36 studies
- Niet-kleincellige longkanker31 studies
- Prostaatkanker27 studies
- Obesitas27 studies
- Acute myeloïde leukemie24 studies
- Metastatische kanker24 studies
- Eierstokkanker23 studies
- Overgewicht23 studies
- Multipel myeloom21 studies
- Colitis ulcerosa21 studies
- Ziekte van Alzheimer20 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.